Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Rating of “Hold” by Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average recommendation of “Hold” from the fifteen brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $26.8462.

A number of brokerages recently weighed in on ACHC. Zacks Research raised shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $24.50 to $30.00 in a research report on Wednesday. UBS Group lifted their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, April 17th. Barclays upped their target price on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. Finally, TD Cowen upped their target price on shares of Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a report on Tuesday, April 28th.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Glenmede Trust Co. NA purchased a new stake in shares of Acadia Healthcare in the first quarter valued at about $239,000. Segall Bryant & Hamill LLC purchased a new stake in shares of Acadia Healthcare in the first quarter valued at about $263,000. Bank of America Corp DE raised its holdings in shares of Acadia Healthcare by 64.7% in the first quarter. Bank of America Corp DE now owns 1,231,172 shares of the company’s stock valued at $28,797,000 after buying an additional 483,649 shares during the last quarter. Amundi raised its holdings in shares of Acadia Healthcare by 2.9% in the first quarter. Amundi now owns 525,084 shares of the company’s stock valued at $12,282,000 after buying an additional 14,796 shares during the last quarter. Finally, California State Teachers Retirement System raised its holdings in shares of Acadia Healthcare by 34.5% in the first quarter. California State Teachers Retirement System now owns 113,420 shares of the company’s stock valued at $2,653,000 after buying an additional 29,096 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC opened at $25.24 on Friday. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $30.20. The stock has a market cap of $2.32 billion, a PE ratio of -2.06, a price-to-earnings-growth ratio of 8.58 and a beta of 0.69. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a fifty day moving average price of $25.36 and a 200 day moving average price of $19.65.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period in the previous year, the company earned $0.40 earnings per share. Acadia Healthcare’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare will post 1.5 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.